These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10915078)

  • 1. Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections.
    Jason J; Buchanan I; Archibald LK; Nwanyanwu OC; Bell M; Green TA; Eick A; Han A; Razsi D; Kazembe PN; Dobbie H; Midathada M; Jarvis WR
    J Infect Dis; 2000 Aug; 182(2):474-81. PubMed ID: 10915078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
    D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
    Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
    J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3 bright lymphocyte population reveal gammadelta T cells.
    Lambert C; Genin C
    Cytometry B Clin Cytom; 2004 Sep; 61(1):45-53. PubMed ID: 15351982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral gamma delta T-cell populations in HIV-infected individuals with mycobacterial infection.
    Ruiz P; Geraldino N
    Cytometry; 1995 Sep; 22(3):211-6. PubMed ID: 8556952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
    Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
    Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.
    Worku S; Gorse GJ; Belshe RB; Hoft DF
    J Infect Dis; 2001 Sep; 184(5):525-32. PubMed ID: 11474428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
    Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Kärre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
    Immunology; 2008 Feb; 123(2):164-70. PubMed ID: 17627773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
    Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients.
    Ahmad R; Sindhu ST; Tran P; Toma E; Morisset R; Menezes J; Ahmad A
    J Med Virol; 2001 Nov; 65(3):431-40. PubMed ID: 11596074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
    Tan DB; Fernandez S; French M; Price P
    Clin Immunol; 2009 Jul; 132(1):63-70. PubMed ID: 19403337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma.
    Hamzaoui A; Kahan A; Ayed K; Hamzaoui K
    Mediators Inflamm; 2002 Apr; 11(2):113-9. PubMed ID: 12061423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
    Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
    Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.